- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.07. | Incyte Completes Vega Therapeutics Acquisition, Adding Novel mAb to Hematology Portfolio | ||
| 06.07. | Novartis Agrees to Acquire Myricx Bio in Push for Next-Generation ADCs | ||
| 30.06. | Two WuXi Biologics Manufacturing Facilities, Packaging Center Get Brazil GMP Certification | ||
| 30.06. | Lilly, Innovent Announce 8th Collaboration, Breast Cancer Treatment Commercialization in China | ||
| 30.06. | Icosagen Completes €45M Biologics Expansion | ||
| 30.06. | Exonate Appoints Olav Helleboe as CEO | ||
| 30.06. | Thermo Fisher Adds KinetiSol Technology at U.S. Drug Sites | ||
| 30.06. | Vect-Horus, Servier Ink CNS Drug Delivery Deal | ||
| 30.06. | Lonza Expands HPAPI Capacity in Visp | ||
| 30.06. | Evotec Makes Continuous Manufacturing Technology Available on a Turnkey Basis | ||
| 30.06. | Ipsen Acquiring Kartos Therapeutics, Bolstering Late-Stage Cancer Pipeline | ||
| 29.06. | Zymeworks to Acquire Theravance, Add COPD Treatment to Portfolio | ||
| 29.06. | Natera, Aveta Biomics Ink Partnership to Support Phase III Trial in Head and Neck Cancer | ||
| 29.06. | Roche, Excalipoint to Collaborate on Evaluation of Candidate for Solid Tumors | ||
| 26.06. | Adragos Pharma Kawagoe, Towa Pharmaceutical Ink Strategic Supply Pact | ||
| 26.06. | Enzene Premieres Nex Partnership Program at BIO 2026 | ||
| 25.06. | Merck KGaA to Acquire Bio-Techne for $11.3B | ||
| 25.06. | DDL Appoints Jennifer Riter as Vice President of Analytical Testing Services | ||
| 25.06. | Agilent Completes Acquisition of Biocare Medical | ||
| 25.06. | Shilpa Biologicals Commissions Integrated ADC Drug Substance GMP Manufacturing Facilities | ||
| 24.06. | SK pharmteco Launches SKyvec Proprietary Multimodal Viral Vector Platform | ||
| 24.06. | Julie Kim Takes Helm as Takeda CEO | ||
| 24.06. | Circio, Tcelltech Enter CAR-T Cell Therapy Research Collaboration | ||
| 24.06. | Abbisko Therapeutics, Lilly Expand R&D Alliance | ||
| 24.06. | Combotope Therapeutics, Boehringer Ingelheim Partner on Tumor-Selective Antibodies for Cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.